Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Lung Cancer
>
2023
>
26
>
4
Volume:
26
Issue:
4
1. Cigarette Smoke Induces Gefitinib Resistance in NSCLC Cells via ROS/Sirt3/SOD2 Pathway.
Page:245—256
2. A Real-world Study on the Incidence and Outcome of Immune-related Adverse Events in Lung Cancer Patients.
Page:257—264
3. Growth Regularity of Pulmonary Ground Glass Nodules Based on 3D Reconstruction Technology.
Page:265—273
4. Prognosis Analysis of Early-stage Non-small Cell Lung Cancer Patients Treated with Stereotactic Body Radiotherapy.
Page:274—280
5. Early Onset Pulmonary Events and Management Strategies during the Treatment of ALK Positive NSCLC Patients with Brigatinib.
Page:281—290
6. Advances in Diagnosis and Treatment of HER2-positive Non-small Cell Lung Cancer.
Page:291—302
7. Advances in Molecular Subtyping, Characteristics and Therapeutic Strategies of Small Cell Lung Cancer.
Page:303—309
8. Progress in the Study of Spindle Assembly Checkpoint in Lung Cancer.
Page:310—318
9. Ceritinib as First-line Treatment for Advanced Lung Adenocarcinoma with COX7A2L-ALK Fusion: A Case Report and Literature Review.
Page:319—324
10. Erratum: Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and Migration of Small Cell Lung Cancer with High c-Myc Expression.
Page:309—309